Salient sues Bovie in electrosurgical patent case
This article was originally published in Clinica
Executive Summary
Salient Surgical Technologies has filed a patent infringement lawsuit against Bovie Medical relating to fluid-assisted electrosurgical technology. Salient claims that its US patent ’579 has been infringed by Bovie’s SEER (saline-enhanced electrosurgical resection) device. Portsmouth, New Hampshire-based Salient originally licensed the patent from Medtronic, which is also a plaintiff in the case. Bovie’s SEER resector delivers saline to an incision and is designed to give surgeons the flexibility to dissect solid organ substances quickly, with reliable haemostasis. Salient’s product portfolio includes salient monopolar sealers for “virtually bloodless solid organ surgery”.